This bill establishes a new interagency Task Force to dismantle foreign scam operations targeting Americans, particularly through "pig butchering" scams in Southeast Asia. The Task Force, chaired by the Secretary of State, will coordinate efforts across multiple agencies to shut down scam centers, impose sanctions on perpetrators, and support victims of trafficking. It requires a detailed strategy within 180 days and annual reports to Congress on progress, including sanctions imposed and funds recovered. The bill authorizes $30 million for these efforts in fiscal years 2026-2027, focusing on countries like Cambodia, Laos, and Burma where scam centers operate with forced labor.
HR 5021, the American Decade of Sports Act, requires the U.S. Department of State to create a formal 5-year strategy (updated every 5 years) for using major international sporting events hosted in the U.S. between 2024 and 2034 - including the 2026 World Cup and 2028 Olympics - to strengthen diplomatic ties and promote U.S. soft power. It mandates renaming the State Department’s sports diplomacy division as the Office of Sports Diplomacy, adding at least 3 dedicated staff members, and coordinating with host cities, sports leagues, and visa agencies to streamline international visitor access. The strategy must detail diplomatic goals, partnerships with local communities and the sports industry, and plans for cultural exchange, while requiring annual progress reports to Congress until 2034. This bill directly affects the State Department, host cities, international athletes, and diplomatic engagement efforts.
S 3302, the Mikaela Naylon Give Kids a Chance Act of 2025, requires drug manufacturers developing cancer treatments to conduct pediatric-focused research for certain drugs targeting pediatric cancer mechanisms. It amends FDA drug approval processes to mandate molecularly targeted pediatric cancer investigations for drugs with new active ingredients or specific approved combinations, ensuring studies address dosing, safety, and efficacy for children. The bill also extends priority review vouchers (which expedite FDA reviews) for rare pediatric disease treatments until 2030 and mandates GAO studies to evaluate how effectively these incentives spur new pediatric cancer drug development. These changes apply to new drug applications submitted three years after the law's enactment, with reports due to Congress at 6, 8, and 10 years.
The Medical Foods and Formulas Access Act of 2025 would require Medicare, Medicaid, CHIP, and the Federal Employees Health Benefits Program to cover medically necessary food for people with specific digestive and metabolic disorders. This includes specialized formulas and nutrients prescribed by healthcare providers for conditions like inherited metabolic disorders, inflammatory bowel disease, and food protein allergies. The bill defines "medically necessary food" to include items such as amino acid preparations, low protein modified foods, and vitamins specifically designed for these conditions, along with necessary medical equipment for administration. Coverage would apply to federal health programs with different effective dates (1-3 years from enactment) and encourages private health insurance plans to provide similar coverage for these life-sustaining treatments.
This bill reorganizes procedural rules for Inspector General (IG) investigations within the Department of Justice (DOJ). It removes specific language that previously restricted IG access to certain allegations involving DOJ personnel, streamlining the investigation process. The key change eliminates an exception clause in existing law, allowing IGs to investigate all DOJ personnel allegations without that prior limitation. This affects how DOJ investigations are conducted but does not create new policies or change substantive rights. (Procedural bill; summary focuses on specific legal reorganization.)
The Kidd's Stuttering Act requires Medicaid and CHIP to screen children aged 2-6 for stuttering and speech fluency during routine well-child visits starting January 1, 2027. It also mandates that Medicaid and CHIP cover specified speech therapy services for childhood stuttering (defined as "specified speech therapy services") with coverage rules no more restrictive than those for other speech disorders like language delays. The bill ensures these services include telehealth options and applies to all states administering Medicaid or CHIP. This directly affects children with stuttering who qualify for Medicaid or CHIP, aiming to improve early detection and access to treatment.
HR 6358, the Veteran Education Empowerment Act, creates a federal grant program to help colleges establish or improve dedicated Student Veteran Centers. These centers provide veterans, active-duty service members, and their families with lounge space, benefits counseling, academic support, and mental health services. Institutions must serve significant numbers of veterans and have sustainability plans to qualify for grants, with funding capped at $500,000 per institution over four years. The bill directly affects colleges serving veterans and aims to address challenges like isolation and transition difficulties through centralized campus support.
HR 5541, the Every Kid Outdoors Reauthorization Act, expands eligibility for the program to include fifth graders (ages 10-11) and home-schooled learners in that age range, replacing the previous requirement for 10-year-olds. The bill authorizes $25 million annually for the National Park Service to support program operations, promote the initiative to schools and families, provide transportation assistance to financially needy schools and organizations, and conduct targeted outreach to underserved communities and children with disabilities. This reauthorization directly affects fifth-grade students and home-schooled learners aged 10-11, as well as schools and youth organizations participating in the program. The key change is broadening the age group served while maintaining the program's funding structure for operational support and equitable access.
Give Kids a Chance Act of 2025 This bill expands the Food and Drug Administration’s (FDA’s) authority with respect to research on rare pediatric diseases, including by permitting the FDA to take enforcement action against drug sponsors that fail to satisfy pediatric study requirements and by reauthorizing programs that support pediatric research. Specifically, the bill modifies requirements relating to molecularly targeted pediatric cancer investigations to permit research on new drugs in combination with active ingredients that have already been approved, provided certain conditions are met; permits the FDA to take enforcement action against drug sponsors that fail to comply with pediatric study requirements, if such sponsors demonstrated a lack of due diligence in satisfying the requirement; renews the FDA’s authority to award priority review vouchers to sponsors of new products intended to treat rare pediatric diseases through September 30, 2029; and reauthorizes through FY2027 certain funding for the National Institutes of Health to support priority pediatric research. The bill also provides statutory authority for the FDA’s interpretation of the orphan drug exclusivity period. The bill specifies, consistent with FDA regulations, that the seven-year market exclusivity period for drugs for rare diseases or conditions (i.e., orphan drugs) prohibits the approval of the same drug for the same approved use or indication with respect to the disease or condition. (In Catalyst Pharmaceuticals, Inc. v. Becerra , a court rejected the FDA’s interpretation and held that orphan drug exclusivity extends to all uses or indications for the disease or condition.)
The Platform Accountability and Transparency Act creates a structured process for researchers to access certain platform data for research while protecting user privacy. Platforms with at least 50 million US monthly users must provide specific data to qualified researchers (affiliated with US universities or nonprofits) whose projects are approved by the National Science Foundation and Federal Trade Commission. The bill requires platforms to publicly disclose information about advertising, algorithms, content moderation, and highly disseminated content, while establishing strict privacy and cybersecurity safeguards for the data. It also creates legal protections for platforms and researchers who comply with the law's requirements, ensuring researchers cannot be sued for accessing data through this process.
This bill updates securities laws to expand exemptions for retirement plans used by charities and educational institutions. It specifically modifies definitions in the Investment Company Act, Securities Act, and Securities Exchange Act to include 403(b) plans meeting certain conditions - such as being subject to ERISA, having employer fiduciary oversight, or being governmental plans. These changes reduce regulatory hurdles for organizations offering these plans, making it easier to administer retirement benefits for their employees. The bill directly affects charities, schools, and other non-profits that sponsor 403(b) retirement plans.
This bill provides $50 million annually from 2026 through 2030 to fund security measures for public transit systems in urbanized areas, removing previous population requirements that limited access. It allows transit agencies to use these funds for hiring additional officers, contracting with local police, and making physical safety upgrades like monitoring devices and operator shields. Additionally, it mandates a study by the National Academies (with input from transit workers) to evaluate crime prevention tactics, including successful and unsuccessful approaches used by transit agencies. The bill directly affects transit agencies and passengers by prioritizing safety infrastructure and data-driven crime reduction strategies.
